Pzena Investment Management LLC Buys 42,184 Shares of Amdocs Limited $DOX

Pzena Investment Management LLC boosted its position in Amdocs Limited (NASDAQ:DOX) by 0.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,593,249 shares of the technology company’s stock after purchasing an additional 42,184 shares during the period. Amdocs comprises approximately 1.8% of Pzena Investment Management LLC’s portfolio, making the stock its 22nd biggest holding. Pzena Investment Management LLC owned 5.84% of Amdocs worth $540,976,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the company. Amundi lifted its position in shares of Amdocs by 73.0% during the 1st quarter. Amundi now owns 13,778 shares of the technology company’s stock valued at $1,217,000 after buying an additional 5,816 shares during the last quarter. Millennium Management LLC raised its stake in Amdocs by 458.3% in the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after acquiring an additional 55,038 shares during the period. Goldman Sachs Group Inc. lifted its holdings in Amdocs by 12.6% during the first quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock valued at $30,300,000 after purchasing an additional 37,087 shares during the last quarter. Empowered Funds LLC boosted its position in Amdocs by 12.0% during the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock worth $1,462,000 after purchasing an additional 1,709 shares during the period. Finally, Jane Street Group LLC increased its stake in shares of Amdocs by 195.4% in the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after purchasing an additional 76,683 shares in the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Price Performance

Shares of NASDAQ:DOX opened at $70.56 on Thursday. The company’s fifty day moving average price is $79.15 and its 200-day moving average price is $81.41. The firm has a market capitalization of $7.62 billion, a price-to-earnings ratio of 13.65, a PEG ratio of 1.22 and a beta of 0.40. Amdocs Limited has a one year low of $66.53 and a one year high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.17.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The firm’s revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.66 EPS. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, equities research analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a dividend yield of 3.2%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s payout ratio is 40.81%.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Barclays dropped their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 4th. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Bank of America lowered their target price on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $92.33.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.